News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
OTC $TREIF CSE $TRUE A.I. Efficient Healthcare Operations as Healthcare organizations are using AI to improve the efficiency of all kinds of processes, from back-office tasks to patient care.https://treatment.com/investors/
Good morning TreatmentAI could help make healthcare operations more efficient.
OTC: $TREIF CSE: $TRUE @TreatmentAI welcomed the recent news of a federal government plan to include a $2.4-billion fund in the upcoming budget intended to help sectors like health and agriculture develop AI strategies. https://treatment.com/federal-funding-could-further-boost-treatment-com-ais-healthcare-initiatives/
OTC: $TREIF .389 +7.16% The #AI Revolution: Is This the Bubble, or the Beginning? https://www.usatoday.com/story/special/contributor-content/2024/05/15/the-ai-revolution-is-this-the-bubble-or-the-beginning/73703356007/ via @usatoday #healthcare #ArtificialIntelligence CSE: $TRUE
$TREIF Strong buy alert - https://www.tradingview.com/symbols/OTC-TREIF/technicals/
CSE: $TRUE OTC: $TREIF +42.86% YTD https://treatment.com/investors/ @TreatmentAI
OTC: $TREIF CSE: $TRUE How Treatment’s Medical AI Outclasses The Competition
To understand why TRUE is so well positioned to dominate, you have to understand what makes its GLM so powerful. https://thecapitalreport.com/true/
OTC: $TREIF $CSE: $TRUE THE NEXT BIG A.I. HEALTHCARE DISCOVERY
A.I. is Making Healthcare Faster, Safer, and More Affordable
That’s Why the Sector is Projected to Grow 32% Annually Through 20301
$TREIF (OTC-BB: $TREIF) (CNSX: TRUE.CN) Multi-Billion Dollar Opportunities with Active tech companies in the markets this week include @TreatmentAI https://stkt.co/VCqE08Rk
Has so much potential. Steal at this price point.
(OTC-BB: $TREIF) (CNSX: TRUE.CN) Artificial Intelligence Enabled Technologies Transforming Healthcare Industry Creating Multi-Billion Dollar Opportunities https://barchart.com/share/news/26222888 via
@Barchart Active tech companies in the markets this week include @TreatmentAI
OTC: $TREIF NEWS OUT! Treatment.com AI CSE: $TRUE Expands Access to GLM
Treatment.com AI and Novus Health Partnership Expands Access to its Global Library of Medicine (GLM) https://finance.yahoo.com/news/treatment-com-ai-novus-health-120000717.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via YahooFinance
OTC: $TREIF CSE: $TRUE Empowering healthcare globally with instantaneous and precise medical insights, through AI
OTC: $TREIF CSE: $TRUE ready to move up again fast! New COO announced for TREATMENT | AI Healthcare tech company transforming patient care with AI-driven Clinical insights and harnessing the collaborative power of accurate knowledge, expertise and the experience of international medical professionals. www.treatment.com
On many people's radars this year. Low float and in the medical #AI sector! $TREIF
CEO of TreatmentAI stated, "We are a healthcare tech company transforming patient care with AI-driven Clinical insights. We are harnessing the collaborative power of accurate knowledge, expertise and experience of int'l medical professionals." https://treatment.com
OTC: $TREIF CSE: $TRUE #AI could help make healthcare operations more efficient. Healthcare organizations are using AI to improve the efficiency of all kinds of processes, from back-office tasks to patient care. @TreatmentAI
https://treatment.com/investors/
OTC: $TREIF CSE: TRUE Treatment.com is the company behind the new release of the Treatment Digital Health App. Check out "Treatment Digital Health Care" https://play.google.com/store/apps/details?id=com.treatment.cara&pcampaignid=web_share via @GooglePlay
$TREIF is excited to announce one of the leading US medical schools has agreed to a contract renewal utilizing Treatment’s Medical Education Suite (“MES”). https://finance.yahoo.com/news/treatment-com-ai-announces-contract-120000509.html
$TREIF NEWS OUT. Treatment.com AI Announces Contract Renewal with Leading US Medical School
https://www.otcmarkets.com/stock/TREIF/news/Treatmentcom-AI-Announces-Contract-Renewal-with-Leading-US-Medical-School?id=438922
News: Treatment.com AI partners with aiXplain Inc. to extend access to its Global Library of Medicine (GLM) -Treatment.com AI Inc.
Wed, Apr 10, 2024, 6:00 AM EDT
In This Article:
TREIF
VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce it has signed a Collaborative Agreement with aiXplain, Inc. (“aiXplain”) to enable greater access to Treatment’s proprietary Global Library of Medicine (“GLM”) by contributing to aiXplain’s ever-growing dynamic Artificial Intelligence (AI) marketplace.
Treatment has partnered with aiXplain, the industry’s first no-code/low-code integrated AI development platform. Over the past 7 years and in collaboration with hundreds of healthcare professionals globally, utilizing proprietary algorithms, Treatment has built the world’s most intelligent, personalized healthcare AI engine, the Global Library of Medicine (GLM). aiXplain’s marketplace makes it possible for healthcare organizations to access Treatment’s AI engine through its development framework and enhance the quality of clinical diagnosis within their organizations across multiple platforms.
Treatment and aiXplain also intend to explore mutually beneficial international opportunities through the partnership. Both parties have a shared interest in the future to provide the GLM in multiple languages.
The collaboration also allows aiXplain and Treatment to work closely on testing and development of further new mutual joint commercial applications and/or solutions. The intent of this collaboration is to promote the development, installation, testing, validation, and commercialization of one or more novel solutions that further the goals of both companies and proactively impact the healthcare market globally.
Dr. Essam Hamza, CEO of Treatment.com AI, comments: “The opportunity to partner with aiXplain, an organization at the heart of the AI evolution, and to be part of their evolving marketplace is fantastic. It helps fulfill our shared philosophies in the democratization of AI. Our goal is to have Treatment’s Global Library of Medicine (GLM) AI accessible to healthcare organizations and healthcare professionals alike, and aiXplain’s marketplace creates new opportunities for all parties.”
"Our partnership with Treatment represents another quality addition to our world-leading marketplace of AI models and assets," said Hassan Sawaf, CEO & Founder of aiXplain. "The news also marks a milestone for aiXplain. This is the first specialized AI model for the healthcare industry to join our marketplace, expanding the versatility of our AI platform across sectors."
About Treatment.com AI Inc.
Treatment.com AI is a company utilizing AI to positively disrupt the healthcare sector and impact current inefficiencies and challenges. Over the past 7+ years and with the input of hundreds of healthcare professionals globally, Treatment.com AI has built the world’s most intelligent, personalized healthcare AI engine, the Global Library of Medicine (GLM). Providing the highest qualified clinical information and support to all healthcare professionals, the GLM delivers >92%+ accuracy on first diagnosis as well as providing recommended tests (physical and lab), x-rays, and billing codes. The platform’s quality and transparency are unrivaled, as the GLM provides an explanation of every step and likelihood associated with every symptom. Treatment.com AI also focuses on the next generation of healthcare professionals supporting Medical and Nursing schools, who utilize the GLM to help enhance the future clinical skills of their students. Treatment.com AI is focused on using AI for good and utilizing its GLM platform to bring the possibility of health equity and inclusion for disenfranchised communities.
About aiXplain Inc.
Founded in 2020, aiXplain has established itself as a pioneering force with the industry's premier no-code/low-code platform for AI development. Designed to democratize the creation and deployment of AI solutions, our platform empowers users to effortlessly develop, manage, benchmark, and deploy AI solutions. With access to an expansive marketplace featuring over 40,000 leading AI models and assets, our customers are equipped to tailor advanced solutions to their specific needs, streamlining the path from concept to deployment. To learn more, visit aixplain.com.
Media Contact
LaunchSquad for aiXplain
aixplain@launchsquad.com
FOR ADDITIONAL INFORMATION, CONTACT:
Dr. Essam Hamza, CEO
ehamza@treatment.com
If you would like to find out more about Treatment’s products and services, please email at info@treatment.com
For media inquiries, contact: media@treatment.com
Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955
Cautionary Statements
This news release contains forward-looking statements that are based on Treatment.com AI’s expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to the implementation of its shareholder communications initiative and the timing thereof. Although Treatment.com believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements, and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and Treatment.com undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law.
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
$TREIF CSE: TRUE.CA News: Treatment.com AI welcomes the Federal Government's announcement of a plan to fund $2.4 billion in its upcoming budget towards Artificial Intelligence (AI) Adoption
https://finance.yahoo.com/news/treatment-com-ai-welcomes-federal-120000957.html
OTC: $TREIF CSE: $TRUE Another Impressive week in the books! #investment #opportunities Treatment.com AI is on the horizon of the #digital #healthcare #revolution https://stockcharts.com/freecharts/symbolsummary.html?sym=TRUE.CA #bullish
$TREIF Strong buy alert - https://www.tradingview.com/symbols/OTC-TREIF/technicals/
OTC: $TREIF CSE: $TRUE Our (GLM) #AI system can support better health decisions for patients, more efficient & effective doctor visits & an integrated experience that improves health outcomes for medical clinics, insurers and governments. http://treatment.com AI
#Bullrun
$TREIF Huge News! Funding from the National Institute of Health, to develop a culturally sensitive #AI approach for collecting family medical history. CSE: $TRUE https://treatment.com/2024/03/27/treatment-com-ai-funded-by-the-national-institute-of-health-to-develop-a-culturally-sensitive-ai-approach-to-health-equity/
$TREIF IS UP +50.3975%
OTC: $TREIF CSE: $TRUE Helping Patients, Providers and Educators https://www.thebullreport.com/true/
$TREIF -Treatment.com AI (CSE: $TRUE) is Making Healthcare Faster, Safer, and More Affordable. #AI #Digital #Healthcare is Projected to Grow 32% Annually Through 2031
OTC: $TREIF CSE: $TRUE Download our Investor Presentation Now: https://treatment.com/wp-content/uploads/2024/03/TREATMENT-INVESTOR-MARCH.pdf "We believe everyone
deserves great health"
OTC: $TREIF CSE: $TRUE Empowering healthcare globally with instantaneous and precise medical insights, through AI
$TREIF $TRUE Treatment has partnered with Rush River Research in Minneapolis to develop an Artificial Intelligence (AI) approach for collecting information about family medical history that is culturally sensitive and appropriate for African-American families. Current methods used by clinicians to collect family medical histories often do not satisfactorily capture important information from blended families or non-traditional relationships commonly found in racial or ethnic minority communities. The historical trauma and systemic bias common in African American communities can limit the amount of information known about the health of relatives. Without better methods for capturing information, existing health disparities addressing prevention and risk can persist. In collaboration with Rush River Research, Treatment is using its proprietary artificial intelligence capabilities to change how family health is collected and recorded to address existing disparities. The Company held multiple focus groups with African American doctors and community members to help develop and prototype culturally sensitive approaches to collecting information about family health.
OTC: $TREIF CSE: $TRUE NEWS! Treatment.com AI Funded by the National Institute of Health to Develop a Culturally Sensitive AI Approach to Health Equity
https://treatment.com/2024/03/27/treatment-com-ai-funded-by-the-national-institute-of-health-to-develop-a-culturally-sensitive-ai-approach-to-health-equity/
#AI #artificalintelligence #healthcare
otc $TREIF cse $TRUE DOWNLOAD OUR INVESTOR PRESENTATION https://www.reddit.com/r/10xPennyStocks/comments/1bozww6/otc_treif_cse_true_download_our_investor/
OTC: $TREIF CSE: $TRUE Treatment is focused on including evidence-based medical information. Including medical education taught in a WHO accredited Medical School or recognized by the World Federation for Medical Education or the Foundation for Advancement of International Medical Education and Research. https://treatment.com/solutions/doctors/ #AI #healthcare
$TREIF strong buy average from barchart https://www.barchart.com/stocks/quotes/TREIF/opinion
CSE: $TRUE, OTC: $TREIF Treatment AI is quickly becoming the best assistant a doctor or nurse could ever ask for https://thebullreport.com/TRUE/
$TREIF Treatment.com AI Inc. offers investors a chance to participate in both the healthcare sector — a sector that makes up 11% of our GDP — and the medical AI space, one of the fastest-growing fields around. Speak with your trusted investment advisor to see if a potential high-growth medical AI company like TRUE makes sense for your portfolio.
|
Followers
|
3
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
67
|
|
Created
|
07/20/21
|
Type
|
Free
|
| Moderators | |||
